Through serendipity, science, and rigor, SpringWorks Therapeutics, a targeted oncology company, marks success with the first FDA-approved treatment for Desmoid Tumor.
Serendipity and science: Building a multibillion-dollar breakthrough in oncology independantexpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from independantexpress.com Daily Mail and Mail on Sunday newspapers.
Item 5.07. SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS.
Edgewise Therapeutics, Inc. held its Annual Meeting of
stockholders on June 9, 2023. The matters voted upon at
the Annual Meeting and. | June 12, 2023
New York, NY (PRWEB) July 05, 2022 The Healthcare Technology Report is pleased to announce The Top 25 Healthcare Technology Leaders of New York for 2022.
SpringWorks Therapeutics Inc (SWTX) to Present Progress Across the Company s Targeted Oncology Portfolio at Virtual R&D Day streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.